期刊文献+

吡格列酮对心肌梗死大鼠心肌能量代谢及血流动力学的影响 被引量:1

Effects of pioglitazone on myocardial energy metabolism and hemodynamics in rats with myocardial infarction
下载PDF
导出
摘要 目的:探讨吡格列酮对心肌梗死后大鼠心肌能量代谢及血流动力学的影响。方法:采用开胸结扎冠状动脉左前降支建立心肌梗死模型,取术后72 h存活的20只大鼠随机分为手术组(MI组,n=10)和吡格列酮干预组(P组,n=10,吡格列酮3 mg.kg-1.d-1灌胃8周),另设假手术组(SH组,n=10)。分别喂养8周后用West-ern blotting法测定大鼠心肌组织中过氧化物酶体增殖物激活受体γ(PPARγ)的蛋白表达水平。用生物组织氧耗测量仪测定线粒体氧化呼吸活性,高效液相层析法(HPLC)法测量线粒体内腺苷酸含量;氚标记二磷酸腺苷([3H]-ADP)掺入法检测线粒体膜腺苷酸转运体(ANT)转运活性,经颈动脉插管测定血流动力学参数,并计算心室重塑指标。结果:与SH组比较,MI组PPARγ的蛋白表达水平明显下调(P<0.01),线粒体内高能磷酸盐含量、呼吸活性和ANT转运活性明显降低(P<0.01),血流动力学指标紊乱(P<0.01);与MI组比较,吡格列酮8周干预升高PPARγ的蛋白表达水平,改善心梗后心衰大鼠线粒体呼吸活性及ANT转运活性,增加线粒体内高能磷酸盐含量(P<0.01),但血流动力学指标改善不显著。结论:心肌梗死后心力衰竭过程中,吡格列酮干预活化PPARγ,升高PPARγ蛋白的表达,可改善心力衰竭大鼠心肌能量代谢;但对血流动力学指标改善不显著。 AIM: To observe the effects of pioglitazone on myocardial energy metabolism and hemodynamics in rats with heart failure after myocardial infarction(MI).METHODS: The model of MI was established by ligation of left anterior descending artery.The 20 surviving rats were randomly divided into MI group(n=10) and pioglitazone intervention group(P group,n=10,pioglitazone 3 mg·kg-1·d-1 orally).The sham-operated rats(SH,n=10) served as controls.Hemodynamic parameters were measured.The ratio of left ventricular weight to body weight(LVW/BW) and the ratio of right ventricular weight to body weight(RVW/BW) were calculated after 8-week treatment.The expression of PPARγ was examined by Western blotting.Mitochondrial respiratory function was determined by Clark oxygen electrodes.The size of adenine acid pool(ATP,ADP and AMP) in mitochondria was measured by HPLC.The adenine nucleotide translocator(ANT) activity was detected by the atractyloside-inhibitor stop technique.RESULTS: Compared with SH group,the protein expression of PPARγ was significantly decreased in MI group(P0.01).The mitochondrial respiratory activity,the transport activity of ANT and the high-energy phosphate content were decreased in MI group(P0.01),and the hemodynamic parameters were in disorder(P0.01).Compared with MI group,the protein expression of PPARγ in P group was significantly increased.The mitochondrial respiratory activity,the high-energy phosphate content,the transport activity of ANT were improved(P0.01).However,the hemodynamic parameters were not significantly changed.CONCLUSION: Pioglitazone increases the protein expression of PPARγ and improves myocardial energy metabolism in the development of heart failure in the rat model of myocardial infarction,but dose not change the hemodynamic parameters significantly.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第7期1342-1346,共5页 Chinese Journal of Pathophysiology
基金 贵州省科学技术基金资助项目(黔科合J字[2008]2298号) 中国科学院"西部之光"人才培养计划基金资助项目(科发人教字[2009]24号)
关键词 吡格列酮 心肌梗死 能量代谢 血流动力学 Pioglitazone Myocardial infarction Energy metabolism Hemodynamics
  • 相关文献

参考文献10

  • 1吴强,杨永曜,杨天和,蔡运昌,李隆贵,胡琴.非诺贝特和吡格列酮对压力过负荷大鼠心室重塑的影响及作用机制[J].中国病理生理杂志,2007,23(9):1688-1691. 被引量:4
  • 2耿登峰,伍卫,雷娟,张燕,王景峰.罗格列酮对心肌梗死大鼠血流动力学及肾素-血管紧张素系统的影响[J].中山大学学报(医学科学版),2004,25(2):114-118. 被引量:13
  • 3Yong-Xu Wang.PPARs: diverse regulators in energy metabolism and metabolic diseases[J].Cell Research,2010,20(2):124-137. 被引量:17
  • 4Joanne S Ingwall.Energy metabolismin heart failure and remod-elling. Cardiovascular Research . 2009
  • 5Bensinger SJ,Tontonoz P.Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature . 2008
  • 6Brown JD,Plutzky J.Peroxisome proliferator-activated re-ceptors as transcriptional nodal points and therapeutic tar-gets. Circulation . 2007
  • 7Poderoso JJ,Fernadez S,Carreras MC,et al.Liver oxygen uptake dependence and mitochondrial function in septic rats. Circulatory Shock . 1994
  • 8Botker H E,Kimose H H,Helligso P,et al.Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue. Journal of Molecular and Cellular Cardiology . 1994
  • 9van Bilsen M,Smeets PJ,Gilde AJ,et al.Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?. Cardiovascular Research . 2004
  • 10Stanley WC,Recchia FA,Lopaschuk GD.Myocardial substrate metabolism in the normal and failing heart. Physiological Reviews . 2005

二级参考文献11

  • 1刘世明,丁月霞,钟赟,刘启才,李冰.PPARs激动剂上调内皮细胞表达eNOS并增加NO生成[J].中国病理生理杂志,2006,22(5):911-914. 被引量:4
  • 2Silvia I Anghel,Walter Wahli.Fat poetry:a kingdom for PPARγ[J].Cell Research,2007,17(6):486-511. 被引量:10
  • 3Gurnell M,Wentworth JM,Agostini M,et al.A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis[J].J Biol Chem,2000,275(8):5754-5759.
  • 4Barger PM,Brandt JM,Leone TC,et al.Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth[J].J Clin Invest,2000,105(12):1723-1730.
  • 5Sahlgren B,Eklof AC,Aperia A.Studies of the renal component of the hypertension in rats with aortic constriction.Role of angiotensin Ⅱ[J].Acta Physiol Scand,1986,127(4):443-448.
  • 6Wayman NS,Hattori Y,McDonald MC,et al.Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size[J].FASEB J,2002,16(9):1027-1040.
  • 7Itoh H,Doi K,Tanaka T,et al.Hypertension and insulin resistance:role of peroxisome proliferator-activated receptor gamma[J].Clin Exp Pharmacol Physiol,1999,26(7):558-560.
  • 8Shimamoto Y,Hirota K,Fukamizu A.Effect of peroxisome proliferator-activated receptor alpha on human angiotensin promoter[J].Int J Mol Med,2004,13(5):729-733.
  • 9Kim SK,Zhao ZS,Lee YJ,et al.Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model[J].Diabetes Metab Res Rev,2003,19(6):487-493.
  • 10黄英,雷立权,高广道,王树人,孙晓明.心肌梗塞大鼠心室胶原生化改建与心脏肾素-血管紧张素系统的关系[J].华西医科大学学报,2001,32(1):9-11. 被引量:3

共引文献31

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部